{"schema_version":"secwatch.filing_event.v1","accession":"0001999371-25-007734","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.276166+00:00","generated_at":"2026-05-19T07:55:20.472639+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Tonix appoints former EVP James Hunter to Board; 7,740 option grant at $34.54","bullets":["Appointment effective June 12, 2025; Hunter served as EVP Commercial from June 2023 to Dec 2024.","Received 7,740 stock options at $34.54, vesting at 2026 annual shareholder meeting.","Hunter led launch of Tonix Medicines and migraine asset acquisitions Zembrace and Tosymra.","Board addition strengthens commercial expertise ahead of potential TNX-102 SL fibromyalgia launch; PDUFA Aug 15, 2025.","Not independent under NASDAQ standards due to prior consulting and employment compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-25-007734","json":"https://secwatch.observer/filing/0001999371-25-007734.json","markdown":"https://secwatch.observer/filing/0001999371-25-007734.md","text":"https://secwatch.observer/filing/0001999371-25-007734.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125007734/0001999371-25-007734-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125007734/tnxp-8k_061325.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T07:55:20.472639+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"45a9856063","claim":"James Hunter was appointed as member of the Board at Tonix Pharmaceuticals Holding Corp..","evidence_excerpt":"appointed James Hunter as a member of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125007734/0001999371-25-007734-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}